In contrast to this, Reddy et al. did not observe any change in ROS levels after NOX2, NOX4, and p22phox knockdown in an FLT3-ITD AML cell line (MOLM-13), although this does not seem to have been replicated in other studies [76]. The gene discussed is NOX4; the disease is acute myeloid leukemia.